Loading clinical trials...

Developing Effectiveness Evaluation and Therapeutic Programs of Rehabilitation | Clinical Trials | Clareo Health

RECRUITING

Developing Effectiveness Evaluation and Therapeutic Programs of Rehabilitation

Developing Clinic-oriented Quantitative Effectiveness Evaluation and Individualized Therapeutic Programs of Rehabilitation

NCT03979235•National Research Center for Rehabilitation Technical Aids

View on ClinicalTrials.gov

Summary

Using robotics, sensors, and sEMG to develop clinic-oriented quantitative effectiveness evaluation and individualized programs of rehabilitation

Detailed Description

Using robotics, sensors, sEMG or other methods to develop clinic-oriented quantitative effectiveness evaluation and individualized programs of rehabilitation

Eligibility

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•no history of psychological/psychotic problems, no history of important diseases.
•patients with motor function impairment such as post stroke hemiplegia.

Exclusion Criteria

•history of psychological/psychotic problems
•cognitively or physically unable to cooperate with the examiner to finish the test

Locations (1)

National Research Center for Rehabilitation Technical Aids

Beijing, China

Key Dates

Start Date

June 5, 2019

Primary Completion Date

December 1, 2026

Completion Date

December 31, 2026

Last Updated

May 23, 2025

Enrollment

ESTIMATED participants

Conditions

Healthy VolunteersMotor DeficitsDysphagia

Interventions

Motor function assessment

DIAGNOSTIC_TEST

Contacts

LT Wang, PhD

CONTACT

86-10-58122882 suhonglun@nrcrta.cn

PX Wei, PhD

CONTACT

86-10-58122921 pengxuwei@gmail.com

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

NCT07310264

Healthy Volunteers (HV)Parkinson's Disease (PD)

View study

RECRUITINGPHASE1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT06342713

Healthy ParticipantsHealthy Subjects+5 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 23, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Developing Effectiveness Evaluation and Therapeutic Programs of Rehabilitation

Inclusion Criteria

Exclusion Criteria

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

A Study of ENX-104 in Healthy Participants

Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

Novel Treatment of Radiation Associated Dysphagia With Statins